Investigation of archaeosomes as carriers for oral delivery of peptides

Biochemical and Biophysical Research Communications

Volumn 394, Issue 2, 2010, Pages 412-417

  Li, Zhengrong ^a   Chen, Jian ^a   Sun, Wenqiang ^a   Xu, Yuhong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Archaeosomes; Caco 2 cells; Insulin; Oral delivery

Indexed keywords

ARCHAEOSOME; DRUG CARRIER; INSULIN; LIPOSOME; UNCLASSIFIED DRUG;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MEMBRANE TRANSPORT; CELL STRAIN CACO 2; CONTROLLED STUDY; DRUG RELEASE; DRUG TRANSPORT; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; INSULIN TREATMENT; MICROENCAPSULATION; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SULFOLOBUS ACIDOCALDARIUS; ZETA POTENTIAL;

ADMINISTRATION, ORAL; CACO-2 CELLS; DRUG CARRIERS; HUMANS; INSULIN; LIPOSOMES; MEMBRANE LIPIDS; PEPTIDES; SULFOLOBUS ACIDOCALDARIUS;

SULFOLOBUS ACIDOCALDARIUS;

EID: 77950188555     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.03.041     Document Type: Article

References (40)

1. Chen H., and Langer R. Oral particulate delivery: status and future trends. Adv. Drug Deliv. Rev. 34 (1998) 339-350
2. Xiong X.Y., Li Y.P., Li Z.L., Zhou C.L., Tam K.C., Liu Z.Y., and Xie G.X. Vesicles from pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery. J. Control. Release 120 (2007) 11-17
3. Alonso-Sande M., Cuna M., Remunan-Lopez C., Teijeiro-Osorio D., Alonso-Lebrero J.L., and Alonso M.J. Formation of new glucomannan-chitosan nanoparticles and study of their ability to associate and deliver proteins. Macromolecules 39 (2006) 4152-4158
4. Li H., Song J.H., Park J.S., and Han K. Polyethylene glycol-coated liposomes for oral delivery of recombinant human epidermal growth factor. Int. J. Pharm. 258 (2003) 11-19
5. Mahato R.I., Narang A.S., Thoma L., and Miller D.D. Emerging trends in oral delivery of peptide and protein drugs. Crit. Rev. Ther. Drug Carrier Syst. 20 (2003) 153-214
6. Morishita M., and Peppas N.A. Is the oral route possible for peptide and protein drug delivery?. Drug Discov. Today 11 (2006) 905-910
7. Woodley J.F. Liposomes for oral administration of drugs. Crit. Rev. Ther. Drug Carrier Syst. 2 (1985) 1-18
8. Kim A., Yun M.O., Oh Y.K., Ahn W.S., and Kim C.K. Pharmacodynamics of insulin in polyethylene glycol-coated liposomes. Int. J. Pharm. 180 (1999) 75-81
9. Rogers J.A., and Anderson K.E. The potential of liposomes in oral drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 15 (1998) 421-480
10. Kisel M.A., Kulik L.N., Tsybovsky I.S., Vlasov A.P., Vorob'yov M.S., Kholodova E.A., and Zabarovskaya Z.V. Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat. Int. J. Pharm. 216 (2001) 105-114
11. Lasic D.D. Novel applications of liposomes. Trends Biotechnol. 16 (1998) 307-321
12. Patel G.B., Agnew B.J., Deschatelets L., Fleming L.P., and Sprott G.D. In vitro assessment of archaeosome stability for developing oral delivery systems. Int. J. Pharm. 194 (2000) 39-49
13. Sprott G.D. Structures of archaeobacterial membrane lipids. J. Bioenerg. Biomembr. 24 (1992) 555-566
14. Choquet C.G., Patel G.B., Sprott G.D., and Beveridge T.J. Stability of pressure-extruded liposomes made from archaeobacterial ether lipids. Appl. Microbiol. Biotechnol. 42 (1994) 375-384
15. Sprott G.D., Dicaire L.P., Fleming L.P., and Patel G.B. Stability of liposomes prepared from archaeobacterial lipids and phosphatidylcholine mixtures. Cell. Mater. 6 (1996) 143-155
16. Patel G.B., and Sprott G.D. Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems. Crit. Rev. Biotechnol. 19 (1999) 317-357
17. Conlan J.W., Krishnan L., Willick G.E., Patel G.B., and Sprott G.D. Immunization of mice with lipopeptide antigens encapsulated in novel liposomes prepared from the polar lipids of various archaeobacteria elicits rapid and prolonged specific protective immunity against infection with the facultative intracellular pathogen, Listeria monocytogenes. Vaccine 19 (2001) 3509-3517
18. Patel G.B., and Chen W. Archaeosome immunostimulatory vaccine delivery system. Curr. Drug Deliv. 2 (2005) 407-421
19. Krishnan L., Dicaire C.J., Patel G.B., and Sprott G.D. Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum. Infect. Immun. 68 (2000) 54-63
20. Krishnan L., Sad S., Patel G.B., and Sprott G.D. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help. J. Immunol. 165 (2000) 5177-5185
21. Omri A., Agnew B.J., and Patel G.B. Short-term repeated-dose toxicity profile of archaeosomes administered to mice via intravenous and oral routes. Int. J. Toxicol. 22 (2003) 9-23
22. Patel G.B., Omri A., Deschatelets L., and Sprott G.D. Safety of archaeosome adjuvants evaluated in a mouse model. J. Liposome Res. 12 (2002) 353-372
23. Lo S.L., and Chang E.L. Purification and characterization of a liposomal-forming tetraether lipid fraction. Biochem. Biophys. Res. Commun. 167 (1990) 238-243
24. Gliozzi A., Relini A., and Chong P.L.G. Structure and permeability properties of biomimetic membranes of bolaform archaeal tetraether lipids. J. Membr. Sci. 206 (2002) 131-147
25. Fan Q., Relini A., Cassinadri D., Gambacorta A., and Gliozzi A. Stability against temperature and external agents of vesicles composed of archael bolaform lipids and egg PC. Biochim. Biophys. Acta 1240 (1995) 83-88
26. Zhang N., Ping Q.N., Huang G.H., and Xu W.F. Investigation of lectin-modified insulin liposomes as carriers for oral administration. Int. J. Pharm. 294 (2005) 247-259
27. Minato S., Iwanaga K., Kakemi M., Yamashita S., and Oku N. Application of polyethyleneglycol (PEG)-modified liposomes for oral vaccine: effect of lipid dose on systemic and mucosal immunity. J. Control. Release 89 (2003) 189-197
28. Lee H., and Park T.G. Preparation and characterization of mono-PEGylated epidermal growth factor: evaluation of in vitro biologic activity. Pharm. Res. 19 (2002) 845-851
29. Song S., Liu D., Peng J., Sun Y., Li Z., Gu J.R., and Xu Y. Peptide ligand-mediated liposome distribution and targeting to EGFR expressing tumor in vivo. Int. J. Pharm. 363 (2008) 155-161
30. Ichikawa H., and Peppas N.A. Novel complexation hydrogels for oral peptide delivery: in vitro evaluation of their cytocompatibility and insulin-transport enhancing effects using Caco-2 cell monolayers. J. Biomed. Mater. Res. A 67 (2003) 609-617
31. Sonaje K., Lin Y.H., Juang J.H., Wey S.P., Chen C.T., and Sung H.W. In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery. Biomaterials 30 (2009) 2329-2339
32. Iwanaga K., Ono S., Narioka K., Morimoto K., Kakemi M., Yamashita S., Nango M., and Oku N. Oral delivery of insulin by using surface coating liposomes. Improvement of stability of insulin in GI tract. Int. J. Pharm. 157 (1997) 73-80
33. Elferink M.G., de Wit J.G., Demel R., Driessen A.J., and Konings W.N. Functional reconstitution of membrane proteins in monolayer liposomes from bipolar lipids of Sulfolobus acidocaldarius. J. Biol. Chem. 267 (1992) 1375-1381
34. Relini A., Cassinadri D., Mirghani Z., Brandt O., Gambacorta A., Trincone A., de Rosa M., and Gliozzi A. Calcium-induced interaction and fusion of archaeobacterial lipid vesicles: a fluorescence study. Biochim. Biophys. Acta 1194 (1994) 17-24
35. Relini A., Cassinadri D., Fan Q., Gulik A., Mirghani Z., de Rosa M., and Gliozzi A. Effect of physical constraints on the mechanisms of membrane fusion: bolaform lipid vesicles as model systems. Biophys. J. 71 (1996) 1789-1795
36. Elferink M.G., de Wit J.G., Driessen A.J., and Konings W.N. Stability and proton-permeability of liposomes composed of archaeal tetraether lipids. Biochim. Biophys. Acta 1193 (1994) 247-254
37. De Boer S.F., Koopmans S.J., Slangen J.L., and Van der Gugten J. Plasma catecholamine, corticosterone and glucose responses to repeated stress in rats: effect of interstressor interval length. Physiol. Behav. 47 (1990) 1117-1124
38. Hidalgo I.J., Raub T.J., and Borchardt R.T. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96 (1989) 736-749
39. Tanaka Y., Taki Y., Sakane T., Nadai T., Sezaki H., and Yamashita S. Characterization of drug transport through tight-junctional pathway in Caco-2 monolayer: comparison with isolated rat jejunum and colon. Pharm. Res. 12 (1995) 523-527
40. Kavimandan N.J., and Peppas N.A. Confocal microscopic analysis of transport mechanisms of insulin across the cell monolayer. Int. J. Pharm. 354 (2008) 143-148